Latest Lead News

Tambourah Metals has raised $3 million through a strategic placement led by Tribeca Investment Partners, boosting funds for its Beatty Park South gold exploration program to $4.5 million.

(E,E)-bisantrene, Race Oncology’s lead anticancer candidate, operates by binding to G4-DNA and RNA structures, revealing a novel mechanism that disrupts key cancer drivers including the MYC gene.

Golden Deeps Ltd reports exceptional high-grade copper, silver, zinc, and germanium results from its Graceland Prospect in Namibia, setting the stage for targeted drilling of Tsumeb-style deposits.

NTAW Holdings has secured an extension on its financial covenant waiver from Commonwealth Bank, easing short-term borrowing pressures while continuing debt repayments.

Lindsay Australia Limited has updated its dividend announcement to include the Dividend Reinvestment Plan (DRP) price at a 5% discount, confirming a fully franked ordinary dividend for the six months ending June 2025.

Prospech Ltd has successfully closed a fully subscribed $1.6 million rights issue, supplemented by a $546,750 follow-on placement, positioning the company to advance drilling and metallurgical programs in Finland and Slovakia.

Austal Limited has reached a confidential equitable adjustment agreement with the US Navy, resolving cost and schedule issues on the T-ATS shipbuilding program and limiting the contract to three vessels.

Podium Minerals has launched a A$12 million capital raising to accelerate development at its Parks Reef platinum group metals project, following a key metallurgical breakthrough and resource upgrades.

Anatara Lifesciences has raised $1.2 million through a discounted share placement to fund its Anti-Obesity project and explore new opportunities. The capital injection reflects strong institutional support amid ongoing pipeline development.

dorsaVi has confirmed its RRAM Reflex Platform achieves biological-grade reflexes with sub-microsecond latency and ultra-low energy use, outperforming leading digital edge AI systems by orders of magnitude.

Radiopharm Theranostics has received a positive safety recommendation to increase the dose of its radiotherapeutic 177Lu-RAD202 in the Phase 1 HEAT trial for HER2-positive advanced solid tumors, signaling promising early results.

Alchemy Resources has delivered compelling assay results from its recent drilling at the Yellow Mountain Project, confirming and extending mineralisation first identified in the 1970s. The standout intercept of 113 metres at 1.17% copper equivalent underscores the project's promising scale and potential.